A Study of Tirzepatide (LY3298176) in Adults With Type 2 Diabetes Switching From a GLP-1 RA (SURPASS-SWITCH-2)
Clinical trial NCT05706506 · COMPLETED
Trial details
- NCT number
- NCT05706506
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-08
- Primary completion
- 2023-10-31
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.